194 related articles for article (PubMed ID: 6952138)
1. Walker carcinoma 256: a model for studies on tumor-induced anorexia and cachexia.
Guaitani A; Recchia M; Carli M; Rocchetti M; Bartosek I; Garattini S
Oncology; 1982; 39(3):173-8. PubMed ID: 6952138
[TBL] [Abstract][Full Text] [Related]
2. Facilitation of cancer-associated anorexia by cholecystokinin.
Willis GL; Sleeman M; Smith GC
Regul Pept; 1988 Feb; 20(2):119-24. PubMed ID: 3163158
[TBL] [Abstract][Full Text] [Related]
3. Animal models for the study of cancer-induced anorexia.
Garattini S; Guaitani A
Cancer Treat Rep; 1981; 65 Suppl 5():23-35. PubMed ID: 6955017
[TBL] [Abstract][Full Text] [Related]
4. Anorexia and cancer in animals and man.
Garattini S; Bizzi A; Donelli MG; Guaitani A; Samanin R; Spreafico F
Cancer Treat Rev; 1980 Sep; 7(3):115-39. PubMed ID: 7004637
[No Abstract] [Full Text] [Related]
5. Changes in blood metabolic parameters during the development of Walker-256 tumour-induced cachexia in rats are not caused by decreased food intake.
Cassolla P; Moreira CC; Liboni TF; Zaia CT; Borba-Murad GR; Bazotte RB; de Souza HM
Cell Biochem Funct; 2012 Jun; 30(4):265-70. PubMed ID: 22179849
[TBL] [Abstract][Full Text] [Related]
6. Two lines of Walker carcinoma 256: their peculiarities and different interactions with the host.
Guaitani A; Della Torre P; Morasca L; Pintus C; Bartosek I
Tumori; 1983 Feb; 69(1):1-9. PubMed ID: 6836744
[TBL] [Abstract][Full Text] [Related]
7. Sodium and the cachexia and hypophagia of tumor growth.
Morrison SD
J Natl Cancer Inst; 1974 Mar; 52(3):869-74. PubMed ID: 4524118
[No Abstract] [Full Text] [Related]
8. Effect of fish oil supplementation for 2 generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats.
Folador A; Hirabara SM; Bonatto SJ; Aikawa J; Yamazaki RK; Curi R; Fernandes LC
Int J Cancer; 2007 Jan; 120(2):344-50. PubMed ID: 17066422
[TBL] [Abstract][Full Text] [Related]
9. Learned food aversions: heterogeneity of animal models of tumor-induced anorexia.
Bernstein IL; Fenner DP
Appetite; 1983 Jun; 4(2):79-86. PubMed ID: 6578702
[TBL] [Abstract][Full Text] [Related]
10. Plasma and brain cholecystokinin levels in cancer anorexia.
Chance WT; van Lammeren FM; Chen MH; Chen WJ; Murphy RF; Joffe SN; Fischer JE
J Surg Res; 1984 May; 36(5):490-8. PubMed ID: 6587166
[TBL] [Abstract][Full Text] [Related]
11. The role of gastric stasis in tumor-induced anorexia in rats.
McCarthy DO; Daun JM
Cancer; 1992 Sep; 70(6):1601-4. PubMed ID: 1516012
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal depletion of hypothalamic dynorphin in anorexic Walker-256 tumor-bearing rats.
Steele TD; Bryant HU; Malven PV; Yim GK
Pharmacol Biochem Behav; 1988 Mar; 29(3):541-5. PubMed ID: 2896361
[TBL] [Abstract][Full Text] [Related]
13. Anorexia and weight loss: indicators of cachexia in small cell lung cancer.
Lindsey AM; Piper BF
Nutr Cancer; 1985; 7(1-2):65-76. PubMed ID: 2999721
[TBL] [Abstract][Full Text] [Related]
14. Increased central serotonergic activity associated with nocturnal anorexia induced by Walker 256 carcinoma.
Nichols M; Maickel RP; Yim GK
Life Sci; 1983 Apr; 32(16):1819-25. PubMed ID: 6188015
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect.
Beluzi M; Peres SB; Henriques FS; Sertié RA; Franco FO; Santos KB; Knobl P; Andreotti S; Shida CS; Neves RX; Farmer SR; Seelaender M; Lima FB; Batista ML
PLoS One; 2015; 10(3):e0122660. PubMed ID: 25807446
[TBL] [Abstract][Full Text] [Related]
16. Assessment of dynorphin-A depletion in the anorexia of Walker-256 tumor bearing rats.
Yim GK; Bryant HU; Malven PV
Physiol Behav; 1985 Jul; 35(1):117-20. PubMed ID: 2865763
[TBL] [Abstract][Full Text] [Related]
17. Effect of infliximab on metabolic disorders induced by Walker-256 tumor in rats.
Miksza DR; de Souza CO; de Morais H; da Rocha AF; Borba-Murad GR; Bazotte RB; de Souza HM
Pharmacol Rep; 2013; 65(4):960-9. PubMed ID: 24145090
[TBL] [Abstract][Full Text] [Related]
18. The significance of learned food aversions in the aetiology of anorexia associated with cancer.
Levine JA; Emery PW
Br J Cancer; 1987 Jul; 56(1):73-8. PubMed ID: 3476146
[TBL] [Abstract][Full Text] [Related]
19. Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15.
Borner T; Arnold M; Ruud J; Breit SN; Langhans W; Lutz TA; Blomqvist A; Riediger T
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):417-427. PubMed ID: 28025863
[TBL] [Abstract][Full Text] [Related]
20. General metabolic abnormalities in cancer patients: anorexia and cachexia.
Holroyde CP; Reichard GA
Surg Clin North Am; 1986 Oct; 66(5):947-56. PubMed ID: 3532380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
